Departments of Environmental and Occupational Health Sciences, University of Washington School of Public Health and Community Medicine, Seattle, WA 98109, USA.
J Am Board Fam Med. 2013 Jul-Aug;26(4):394-400. doi: 10.3122/jabfm.2013.04.120274.
To conduct a survey of primary care physicians and advanced registered nurse practitioners (ARNPs) in Washington State (WA) focused on changes in practice patterns and use of support tools in the prescription of opioids for the treatment of chronic noncancer pain (CNCP).
A convenience sample of primary care providers in WA was obtained from diverse geographic regions and health care organizations. The web-based anonymous survey was conducted in March-August 2011.
Among 856 provider respondents, 623 reported treating patients with CNCP and served as the analysis sample. Most providers (72%) reported concern about opioid overdose, addiction, dependence, or diversion. Only 25% indicated concern about regulatory scrutiny. Only a small proportion of providers overall (3.3%) reported that they had stopped prescribing opioids for CNCP, but twice as many ARNPs (5.8%) as physicians (MDs and osteopaths) (2.1%) reported this. A greater proportion of physicians (70.9%) than ARNPs (40.1%) reported familiarity with the Washington State opioid dosing guidelines. Physicians in a large health plan with substantial infrastructure support reported less concern about opioids compared with providers in other settings. Of providers in Spokane (the largest city in Eastern Washington), 45% reported very low capacity to access pain specialty consultation. The vast majority of providers reported a need to access more efficient, innovative means of support and education related to treating patients with CNCP, such as telemedicine consultation.
Overall, prescribing providers in WA reported ongoing concerns regarding opioid use for CNCP, but those affiliated with a health care organization with opioid prescribing guidelines and access to pain consultation were less likely to report being concerned about opioid-related problems or to have discontinued prescribing opioids.
对华盛顿州(WA)的初级保健医生和高级注册护士从业者(ARNPs)进行调查,重点关注在开具治疗慢性非癌痛(CNCP)的阿片类药物处方方面,实践模式和使用支持工具的变化。
从不同地理位置和医疗保健组织中获得了 WA 的初级保健提供者的便利样本。该基于网络的匿名调查于 2011 年 3 月至 8 月进行。
在 856 名提供者应答者中,有 623 名报告治疗了患有 CNCP 的患者,并作为分析样本。大多数提供者(72%)表示担心阿片类药物过量、成瘾、依赖或转移。只有 25%的人表示担心监管审查。总体而言,只有一小部分提供者(3.3%)报告他们已经停止为 CNCP 开具阿片类药物,但 ARNPs(5.8%)的比例是医生(MD 和整骨医生)(2.1%)的两倍。更多的医生(70.9%)比 ARNPs(40.1%)报告熟悉华盛顿州阿片类药物剂量指南。与其他环境中的提供者相比,拥有大量基础设施支持的大型医疗计划中的医生报告对阿片类药物的担忧较少。在斯波坎(华盛顿州东部最大的城市)的提供者中,有 45%报告说获取疼痛专科咨询的能力非常低。绝大多数提供者报告说需要获得更有效、创新的支持手段和与治疗 CNCP 患者相关的教育,例如远程医疗咨询。
总体而言,WA 的处方提供者报告称,他们对 CNCP 使用阿片类药物的问题仍然存在担忧,但与有阿片类药物处方指南和获得疼痛咨询的医疗保健组织有关联的提供者不太可能报告对阿片类药物相关问题的担忧,或者已经停止开具阿片类药物。